PPTA Europe’s Post

As someone who did not match the first time for residency it is important to know that there are lots of great resources out there like this one to help you navigate phase II.

💡 Spotlight on Today's LISA Hero: Alexander Herzog 💡 Alexander is Secretary General at PHARMIG, the Association of the Austrian Pharmaceutical Industry. He is also Member of the Council at IFPMA - International Federation of Pharmaceutical Manufacturers & Associations and Member of the Advisory Board of LISA - Life Science Austria. 🎤 Alexander, what is your role in the Life Science ecosystem? 🔊 In PHARMIG, we represent the entire pharmaceutical industry in Austria, from small companies to large corporations, whether research or sales subsidiaries. We do everything in our power to strengthen Austria as a pharmaceutical location and to keep it internationally competitive. Because one thing is clear to us and we always focus on it: our industry, and therefore also the life science sector, are industries of the future. Strengthening them brings multiple benefits. 🎤 How do you perceive Austria as a location for life sciences? 🔊 We have a very good infrastructure in Austria, enormously committed and competent researchers and can therefore also compete internationally in the life science sector. There are many hidden champions in Austria that play a part in the global market or are even global market leaders. The life science sector is really leading the way here! 🎤 What are the trends you observe in the Life Science sector in Austria? 🔊 According to the latest media reports, the total volume of #investment has fallen from 1 billion Euro to 700 million Euro in 2023. At the same time we see a certain awareness at a political level that we have a vibrant and internationally competitive life science sector in Austria. It is therefore all the more important not to threaten this by investing less, but quite the opposite: to keep at it in order to remain internationally competitive. Photo Credit: © Stefan Csaky

Thanks for your Feedback Hadeel Althagafi "Your Guide for Pharmaceutical Industry" is an essential course for all who are interested in working and investing in Pharmaceutical industry. Learn more about the course from the below 🔗:- https://lnkd.in/dYxwcPWt #pharmaceuticalindustry #Know_How_Academy #pharmacist #drugdiscovery #pharmajob #pharmajobs #formulation #pharmaceutical #drugdevelopment #clinicaltrials #genericmedicine #Genericdrugs #healthcare #bills #syrup #capsule #injection #pharmacovigilance #researchanddevelopment #qualitycontrol #methodology #analytical #tablet #cphi #Pharmaceuticalindustry #Pharma #Pharmajobs #Pharmaceuticals #drugdevelopment #genericmedicine #Genericdrugs #healthcare #bills #Syrup #Capsule #injection #pharmacovigilance #researchanddevelopment #qualitycontrol #methodology #analyticalchemistry #tablet #cphi #bills #pharmaceuticals #pharmaceuticalmanufacturing #enteric #BMR #BPR #Validation #qualityassurance #quality #QC #RD #planning #supplychain #RMPM #rawmaterial #stability #warehouse #USFDA #FDA #SFDA #Guidance #ICH #EMA #CDER #ANDA #NDA #IND

Pleased to share that I've recently completed the 'Your Guide for Pharmaceutical Industry' course from Know-How Academy ✨💊! This comprehensive course provided invaluable insights into the pharmaceutical industry, equipping me with the skills to make a meaningful impact in the pharmaceutical industry field. I truly want to extend my deepest appreciation to the wonderful duo, Dr. Ahmed Nabil and PHD.Salah Al-anazi for their invaluable contribution to this opportunity! 🙏🏻 EXCITED TO APPLY WHAT I HAVE LEARNED #PharmaceuticalIndustry #ContinuousLearning"

Reflecting on valuable information sharing between national trade associations This morning, I had the privilege of joining an insightful conversation and information sharing between industry experts from The Association of the British Pharmaceutical Industry (ABPI) and Danish Association of the Pharmaceutical Industry - Lif - Lægemiddelindustriforeningen The conversation focused on regulatory value and access policy environment for medicines in the UK and Denmark, sharing notes on current complexities, challenges and opportunities within the regulatory frameworks and the UK's appeal as a destination for life sciences investment. Key takeaways include the potential for regulatory improvements, the impact of international collaborations, and innovative pathways to market access for new medicines in both territories, underscoring the necessity of a patient-centric approach in developing regulatory systems for innovation in the pharmaceutical landscape Thanks to Daniel O'Connor, Orban Holdgate, Andy Collier, Louise Broe, Pernille Langgaard-Lauridsen, Thomas Klit Christensen and Joakim Steen Barron-Mikkelsen for a constructive and enlightening session. More of this please! #PharmaceuticalIndustry #RegulatoryAffairs #HealthTechnologyAssessment #InnovationInHealthcare #RegulatoryInnovation

The APhA: Driving the Evolution of Pharmacist Practice The American Pharmacists Association (APhA) has been a crucial force in shaping the role of pharmacists in healthcare. From advocating for expanded clinical responsibilities to supporting pharmacists in becoming vital members of the healthcare team, the APhA has helped elevate the profession to new heights. As we look toward the future, APhA’s ongoing support will continue to empower pharmacists to take on even greater roles in patient care, immunizations, chronic disease management, and personalized medicine. With APhA behind us, the future of pharmacy is brighter than ever, ensuring that pharmacists remain at the forefront of improving patient outcomes. #PharmacyFuture #APhASupport #PharmacistEvolution #HealthcareTransformation #APhM2024 #PharmacistsMonth

🎉 Exciting News! 🎉 Thrilled to announce that I have joined the esteemed team at the Journal of Pharmaceutical Policy and Practice as a member of the Associate Editors! 📚💊 I want to express my sincere gratitude to Zaheer-Ud-Din Babar for entrusting me with this role. It is an incredible honor to contribute to such a reputable journal dedicated to advancing pharmacy practice and policy. 💡 Looking forward to this enriching journey! #PharmacyPractice #JournalEditorial #PharmacyPolicy Journal of Pharmaceutical Policy and Practice

With less than 2 weeks remaining, Ahmed I Yakasai, mni, FPSN Former President of the Pharmaceutical Society of Nigeria and Chairman of Pharma West Africa, invites you to join the conversation. Delve into the insights that make Pharma West Africa a pivotal event in the pharmaceutical industry. Register now and ensure you're part of this enlightening experience! 💼🌍 https://lnkd.in/djeJ8xJw #PharmaWestAfrica #RegisterNow #IndustryInsights

I'm excited to share that I recently attended the "Advancing Generic Drug Development: Translating Science to Approval - 2024" workshop organized by the U.S. Food and Drug Administration (FDA). This two-day event, held on September 24-25, 2024, provided invaluable insights into the latest advancements in generic drug development and regulation. Key Highlights: ▪ Explored cutting-edge scientific and regulatory advancements in the generic drug industry ▪ Gained deep understanding of the FDA's Generic Drug User Fee Amendments (GDUFA) Science and Research Program ▪ Learned about innovative methodologies for in vitro characterization and research supporting guidance development for complex products ▪ Engaged with FDA experts on critical aspects of improving generic drug development This workshop has equipped me with actionable knowledge to contribute more effectively to the evolving landscape of generic drug development. I'm grateful for the opportunity to enhance my expertise in this crucial area of pharmaceutical science and regulation. #GenericDrugs #PharmaceuticalIndustry #ProfessionalDevelopment #FDA #ContinuingEducation

An awesome CMC LATAM 2024 session 1 focusing on regulatory challenges and transformative solutions is in play now. As a scientific committee member I am excited to see it unfold with Session 1. #Casss #cmclatam2024 #regulatory #biopharmaceuticals